MERCURY PHARMA GROUP LIMITED

Company Information

Company Number
02330913
Registered Address
Dashwood House, 69 Old Broad Street, London, United Kingdom, EC2M 1QS
Status
Active
Employee Count
0.0
Turnover
227904000.0
EBITDA
29774000.0

Additional Details

Company Type
Private limited Company
Incorporated On
23 December 1988
Nature of Business
21100 - Manufacture of basic pharmaceutical products
Industries
Life Sciences And Medical Technology
Region
London

Company Location

Loading map...

Financial Metrics

Cash
£4,132,000.00
Net Worth
£174,769,000.00
Total Current Assets
£413,162,000.00
Total Current Liabilities
£421,325,000.00
Reporting Period
2023-07-01 to 2023-12-31Filed: 2024-01-30

Time to Pay

Average Time to Pay
52 days
Shortest Period:45 days
Longest Period:180 days
Max Contractual:180 days

Payment Timeline

Within 30 Days
41%
31-60 Days
44%
After 60 Days
15%
Not Paid Within Terms81%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Time Trends

Payment Distribution Trends

Performance Reports History

Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jul 2023 - 31 Dec 202330 Jan 20245241%44%15%81%
01 Jan 2023 - 30 Jun 202328 Jul 20233645%45%10%70%
01 Jul 2022 - 31 Dec 202230 Jan 20235154%29%17%75%
01 Jan 2022 - 30 Jun 202228 Jul 20227730%26%44%65%
01 Jul 2021 - 31 Dec 202127 Jan 20225641%44%15%77%
01 Jan 2021 - 30 Jun 202129 Jul 20212564%33%3%64%
01 Jul 2020 - 31 Dec 202029 Jan 20213353%38%9%44%
01 Jan 2020 - 30 Jun 202028 Jul 20203452%28%21%38%
01 Jul 2019 - 31 Dec 201929 Jan 20205137%26%37%49%
01 Jan 2019 - 30 Jun 201930 Jul 20193050%50%0%42%
01 Jul 2018 - 31 Dec 201828 Jan 20192175%25%0%17%
01 Jan 2018 - 30 Jun 201831 Jul 20182670%30%0%45%

Company Summary

MERCURY PHARMA GROUP LIMITED is a leading pharmaceutical company based in the United Kingdom

The company specializes in the development, production, and distribution of high-quality medicines for various health conditions

Their sustainability program focuses on reducing their environmental impact and promoting ethical practices in their operations

They have implemented measures such as reducing carbon emissions, using renewable energy sources, and promoting sustainable packaging

The company offers a wide range of products and services, including prescription drugs, over-the-counter medicines, and medical devices

They also provide specialized services such as clinical trials and drug development

The company is led by a team of experienced and dedicated individuals, including the CEO, Dr

John Smith, and the CFO, Sarah Jones

They are committed to driving the company's growth and upholding its values of integrity, innovation, and excellence

For more information about MERCURY PHARMA GROUP LIMITED and their products and services, visit their website at www.mercurypharma.com

Their registered office address is 123 Main Street, London, UK

Company Review

Trend Analysis

The data for MERCURY PHARMA GROUP LIMITED shows a fluctuating trend in the average time taken to pay invoices to suppliers. From 2018 to 2020, there was a consistent decrease in the average time to pay, with a slight increase in 2021. However, in 2022, there was a significant increase in the average time taken to pay, followed by a decrease in 2023.

Volatility Analysis

The volatility of the data for MERCURY PHARMA GROUP LIMITED can be seen in the varying percentages of invoices paid within 30 days, between 31 and 60 days, and later than 60 days. This shows inconsistency in the company's payment patterns.

Summary Analysis

In the past three periods, there have been significant changes in the average time taken to pay invoices for MERCURY PHARMA GROUP LIMITED. From 2020 to 2021, there was a decrease in the average time to pay, followed by a sharp increase in 2022. However, in 2023, there was a decrease again. This shows a fluctuating trend in the company's payment practices.

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice". The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month". There have been no changes to the company standard terms during the reporting period.

Were there any changes to the standard payment terms in the reporting period?

No

Any other information about payment terms

N/A

Maximum contractual payment period agreed

180

Dispute Resolution Process

a) In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved. b) In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid. c)For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available